Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5632-5635

  Zhang, Zhijian ^a,b   Wang, Yufeng ^a   Pang, Yu ^a,b   Liu, Changting ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; BACTERIAL PROTEIN; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BROTH DILUTION; GROWTH RATE; INTERMETHOD COMPARISON; MGIT TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 84906100376     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02778-14     Document Type: Article

References (20)

1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. 2010. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843. http://dx.doi.org/10.1016/S0140-6736(10)60410-2.
2. Muller B, Borrell S, Rose G, Gagneux S. 2013. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet. 29:160-169. http://dx.doi.org/10.1016/j.tig.2012.11.005.
3. Folkvardsen DB, Thomsen VO, Rigouts L, Rasmussen EM, Bang D, Bernaerts G, Werngren J, Toro JC, Hoffner S, Hillemann D, Svensson E. 2013. Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods. J. Clin. Microbiol. 51:4220-4222. http://dx.doi.org/10.1128/JCM.01602-13.
4. zur Wiesch PA, Kouyos R, Engelstadter J, Regoes RR, Bonhoeffer S. 2011. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 11:236-247. http://dx.doi.org/10.1016/S1473- 3099(10)70264-4.
5. Rinder H. 2001. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J. Med. Microbiol. 50:1018-1020. (Pubitemid 33108906)
6. Zhang X, Zhao B, Huang H, Zhu Y, Peng J, Dai G, Jiang G, Liu L, Zhao Y, Jin Q. 2013. Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China. J. Antimicrob. Chemother. 68:1537-1542. http://dx.doi.org/10.1093/jac/dkt082.
7. Kumar P, Balooni V, Sharma BK, Kapil V, Sachdeva KS, Singh S. 2014. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. Tuberculosis (Edinb.) 94:73-80. http://dx.doi.org/ 10.1016/j.tube.2013.10.001.
8. Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H, Song Y, Shang Y, Wang S, Zhao YL. 2012. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7:e32976. http://dx.doi.org/10.1371/journal.pone.0032976.
9. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y. 2012. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366:2161-2170. http://dx.doi.org/10.1056/NEJMoa1108789.
10. World Health Organization. 2009. Guidelines for surveillance of drug resistance in tuberculosis, 4th ed. WHO/HTM/TB/2009.422. World Health Organization, Geneva, Switzerland.
11. Pang Y, Liu G, Wang Y, Zheng S, Zhao YL. 2013. Combining COLD-PCR and high-resolution melt analysis for rapid detection of low-level, rifampin-resistant mutations in Mycobacterium tuberculosis. J. Microbiol. Methods 93:32-36. http://dx.doi.org/10.1016/j.mimet.2013.01.008.
12. Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. 2013. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 57:893-900. http://dx.doi.org/10.1128/AAC.01024-12.
13. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366. (Pubitemid 28060296)
14. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46:2720-2722. http://dx.doi.org/10.1128/AAC.46.8.2720-2722.2002.
15. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. 2012. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa. BMC Infect. Dis. 12:369. http://dx.doi.org/10.1186/1471-2334-12-369.
16. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rusch-Gerdes S, Wright A. 2009. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501-3506. http://dx.doi.org/10.1128/JCM.01209-09.
17. Van Deun A, Aung KJ, Bola V, Lebeke R, Hossain MA, de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC. 2013. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J. Clin. Microbiol. 51:2633-2640. http://dx.doi.org/10.1128/JCM.00553-13.
18. Suo J, Chang CE, Lin TP, Heifets LB. 1988. Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan. Am. Rev. Respir. Dis. 138:999-1001. http://dx.doi.org/10.1164/ajrccm/ 138.4.999.
19. Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF. 2007. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873. http://dx.doi.org/10.1093/jac/dkm054.
20. Zhang Z, Wang Y, Pang Y, Kam KM. 2014. Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 52:638-641. http://dx.doi.org/10.1128/JCM.02713-13.